StockNews.com initiated coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a report issued on Friday. The firm issued a sell rating on the stock.
Separately, HC Wainwright upped their price objective on SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th.
Get Our Latest Stock Analysis on SenesTech
SenesTech Trading Up 6.7 %
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Recommended Stories
- Five stocks we like better than SenesTech
- 3 Tickers Leading a Meme Stock Revival
- Power Up: Gaming Industry Expansion Fuels Stock Opportunities
- Do ETFs Pay Dividends? What You Need to Know
- These 3 Quirky ETFs May Be Strong Plays in 2025
- Trading Stocks: RSI and Why it’s Useful
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.